bibliographic resource 1948108 [br/1948108]
https://w3id.org/oc/corpus/br/1948108

is a

• document
• article

title

• Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma

publication date

• 2008-01-01

contributor

• https://w3id.org/oc/corpus/ar/6934395
• https://w3id.org/oc/corpus/ar/6934396
• https://w3id.org/oc/corpus/ar/6934397
• https://w3id.org/oc/corpus/ar/6934398
• https://w3id.org/oc/corpus/ar/6934399
• https://w3id.org/oc/corpus/ar/6934400
• https://w3id.org/oc/corpus/ar/6934401
• https://w3id.org/oc/corpus/ar/6934402
• https://w3id.org/oc/corpus/ar/6934403
• https://w3id.org/oc/corpus/ar/6934404
• https://w3id.org/oc/corpus/ar/6934405
• https://w3id.org/oc/corpus/ar/6934406
• https://w3id.org/oc/corpus/ar/6934407
• https://w3id.org/oc/corpus/ar/6934408

format

• https://w3id.org/oc/corpus/re/996440

identifier

• https://w3id.org/oc/corpus/id/3576938
• https://w3id.org/oc/corpus/id/3576939
• https://w3id.org/oc/corpus/id/3576940
• https://w3id.org/oc/corpus/id/3576941

part of

• https://w3id.org/oc/corpus/br/60862